Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis

INTRODUCTION: Erythropoiesis-stimulating agents are associated with increased cardiovascular risk when higher doses are used toward higher hematocrit targets. Patients new to dialysis are at higher risk for morbidity and mortality. Systematic evaluation of this population was predefined in the roxad...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Kidney Int Rep
Autors principals: Provenzano, Robert, Fishbane, Steven, Szczech, Lynda, Leong, Robert, Saikali, Khalil G., Zhong, Ming, Lee, Tyson T., Houser, Mark T., Frison, Lars, Houghton, John, Little, Dustin J., Peony Yu, Kin-Hung, Neff, Thomas B.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7938204/
https://ncbi.nlm.nih.gov/pubmed/33732976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2020.12.018
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars